Display options
Share it on

EClinicalMedicine. 2021 Sep;39:101075. doi: 10.1016/j.eclinm.2021.101075. Epub 2021 Sep 03.

Racial and ethnic disparity in clinical outcomes among patients with confirmed COVID-19 infection in a large US electronic health record database.

EClinicalMedicine

Ami R Buikema, Paul Buzinec, Misti L Paudel, Katherine Andrade, Jonathan C Johnson, Yvette M Edmonds, Sumit K Jhamb, Benjamin Chastek, Harish Raja, Feng Cao, Erin M Hulbert, Stephanie Korrer, Dibyajyoti Mazumder, Jerry Seare, Brian K Solow, U Michael Currie

Affiliations

  1. Optum, Eden Prairie, MN, USA.
  2. Optum, Noida, India.
  3. Optum, Boston, MA, USA.
  4. Optum, Irvine, CA, USA.
  5. UnitedHealth Group, Minnetonka, MN, USA.

PMID: 34493997 PMCID: PMC8413267 DOI: 10.1016/j.eclinm.2021.101075

Abstract

BACKGROUND: Racial and ethnic minority groups have been disproportionately affected by the US coronavirus disease 2019 (COVID-19) pandemic; however, nationwide data on COVID-19 outcomes stratified by race/ethnicity and adjusted for clinical characteristics are sparse. This study analyzed the impacts of race/ethnicity on outcomes among US patients with COVID-19.

METHODS: This was a retrospective observational study of patients with a confirmed COVID-19 diagnosis in the electronic health record from 01 February 2020 through 14 September 2020. Index encounter site, hospitalization, and mortality were assessed by race/ethnicity (Hispanic, non-Hispanic Black [Black], non-Hispanic White [White], non-Hispanic Asian [Asian], or Other/unknown). Associations between racial/ethnic categories and study outcomes adjusted for patient characteristics were evaluated using logistic regression.

FINDINGS: Among 202,908 patients with confirmed COVID-19, patients from racial/ethnic minority groups were more likely than White patients to be hospitalized on initial presentation (Hispanic: adjusted odds ratio 1·690, 95% CI 1·620-1·763; Black: 1·810, 1·743-1·880; Asian: 1·503, 1·381-1·636) and during follow-up (Hispanic: 1·700, 1·638-1·764; Black: 1·578, 1·526-1·633; Asian: 1·391, 1·288-1·501). Among hospitalized patients, adjusted mortality risk was lower for Black patients (0·881, 0·809-0·959) but higher for Asian patients (1·205, 1·000-1·452).

INTERPRETATION: Racial/ethnic minority patients with COVID-19 had more severe disease on initial presentation than White patients. Increased mortality risk was attenuated by hospitalization among Black patients but not Asian patients, indicating that outcome disparities may be mediated by distinct factors for different groups. In addition to enacting policies to facilitate equitable access to COVID-19-related care, further analyses of disaggregated population-level COVID-19 data are needed.

© 2021 The Authors.

Keywords: COVID-19; Electronic Health Records; Ethnic Groups; Minority Groups; Retrospective Studies; SARS-CoV-2; United States

Conflict of interest statement

Ami Buikema, Paul Buzinec, Katherine Andrade, Jonathan Johnson, Yvette Edmonds, Sumit Jhamb, Benjamin Chastek, Harish Raja, Feng Cao, Erin Hulbert, Stephanie Korrer, Dibyajyoti Mazumder, Jerry Seare,

References

  1. Am J Ind Med. 2020 Sep;63(9):817-820 - PubMed
  2. Int J Environ Res Public Health. 2020 Jun 17;17(12): - PubMed
  3. JAMA Netw Open. 2020 Aug 3;3(8):e2018039 - PubMed
  4. BMJ Open. 2020 Aug 11;10(8):e039849 - PubMed
  5. J Racial Ethn Health Disparities. 2021 Jun 11;: - PubMed
  6. Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620943671 - PubMed
  7. Health Serv Res. 2012 Dec;47(6):2353-76 - PubMed
  8. J Urban Health. 2016 Jun;93(3):456-67 - PubMed
  9. J Gen Intern Med. 2020 Oct;35(10):3097-3099 - PubMed
  10. Mt Sinai J Med. 2010 Mar-Apr;77(2):166-77 - PubMed
  11. JAMA Netw Open. 2021 Jun 1;4(6):e2112842 - PubMed
  12. EClinicalMedicine. 2020 Aug;25:100455 - PubMed
  13. J Occup Environ Med. 2020 Oct;62(10):e598-e599 - PubMed
  14. Am J Public Health. 2009 Jul;99(7):1293-9 - PubMed
  15. N Engl J Med. 2020 Jun 25;382(26):2534-2543 - PubMed
  16. Ann Intern Med. 2021 Aug;174(8):1183-1186 - PubMed
  17. Diabetes Care. 2020 Jul;43(7):e72-e74 - PubMed
  18. MMWR Morb Mortal Wkly Rep. 2020 Aug 21;69(33):1122-1126 - PubMed
  19. Health Aff (Millwood). 2021 May;40(5):802-811 - PubMed
  20. JAMA Netw Open. 2020 Dec 1;3(12):e2026881 - PubMed
  21. Brain Behav Immun. 2020 Aug;88:66-67 - PubMed
  22. JAMA Intern Med. 2021 Jan 1;181(1):131-134 - PubMed
  23. JAMA Netw Open. 2020 Jun 1;3(6):e2012403 - PubMed
  24. Toxicol Ind Health. 2020 Sep;36(9):689-702 - PubMed
  25. J Infect Dis. 2020 Nov 13;222(12):1951-1954 - PubMed
  26. J Intern Med. 2020 Oct;288(4):479-480 - PubMed
  27. Am J Epidemiol. 2011 Mar 15;173(6):676-82 - PubMed
  28. Radiology. 2020 Dec;297(3):E303-E312 - PubMed
  29. Behav Med. 2019 Apr-Jun;45(2):102-117 - PubMed
  30. Health Aff (Millwood). 2020 Jul;39(7):1253-1262 - PubMed
  31. Public Health Rep. 2014 Jan-Feb;129 Suppl 2:19-31 - PubMed
  32. J Health Care Poor Underserved. 2019;30(3):986-1000 - PubMed
  33. Clin Infect Dis. 2020 Aug 22;: - PubMed
  34. Ann Intern Med. 2021 Jun;174(6):786-793 - PubMed
  35. Int J Environ Res Public Health. 2019 Sep 06;16(18): - PubMed
  36. J Natl Med Assoc. 2021 Apr;113(2):125-132 - PubMed
  37. Nutr Metab Cardiovasc Dis. 2020 Jul 24;30(8):1236-1248 - PubMed
  38. JAMA. 2020 Jun 23;323(24):2466-2467 - PubMed
  39. JAMA Netw Open. 2020 Aug 3;3(8):e2018696 - PubMed
  40. J Med Virol. 2021 Feb;93(2):1045-1056 - PubMed

Publication Types